# FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/fda-approval-summary-atezolizumab-and-durvalumab-in-combination-with-platinum/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Luckson Mathieu,Sujay Shah,Lee H. Pai-Scherf,Erin Larkins,Jonathon Vallejo,Xiaoxue Li,Lisa Rodríguez,Pallavi S. Mishra‐Kalyani,Kirsten B. Goldberg,Paul G. Kluetz,Marc R. Theoret,Julia A. Beaver,Richard Pazdur,Harpreet Singh |
| Citations | 145 |
| DOI | 10.1002/onco.13752 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://academic.oup.com/oncolo/article-pdf/26/5/433/41923675/oncolo_26_5_433.pdf |
| OpenAlex ID | https://openalex.org/W3134820202 |
| PMID | 33687763 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Xiaoxue Li](https://scholariq.org/researchers/xiaoxue-li/)

## Paper journal

- [The Oncologist](https://scholariq.org/journals/the-oncologist/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.